263 related articles for article (PubMed ID: 15623618)
1. Immunohistochemical and molecular analysis of human melanomas for expression of the human cancer-testis antigens NY-ESO-1 and LAGE-1.
Vaughan HA; Svobodova S; Macgregor D; Sturrock S; Jungbluth AA; Browning J; Davis ID; Parente P; Chen YT; Stockert E; St Clair F; Old LJ; Cebon J
Clin Cancer Res; 2004 Dec; 10(24):8396-404. PubMed ID: 15623618
[TBL] [Abstract][Full Text] [Related]
2. Quantitative real-time RT-PCR analysis of NY-ESO-1 and LAGE-1a mRNA expression in normal tissues and tumors, and correlation of the protein expression with the mRNA copy number.
Sato S; Noguchi Y; Wada H; Fujita S; Nakamura S; Tanaka R; Nakada T; Hasegawa K; Nakagawa K; Koizumi F; Ono T; Nouso K; Jungbluth A; Chen YT; Old LJ; Shiratori Y; Nakayama E
Int J Oncol; 2005 Jan; 26(1):57-63. PubMed ID: 15586225
[TBL] [Abstract][Full Text] [Related]
3. NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer.
Odunsi K; Jungbluth AA; Stockert E; Qian F; Gnjatic S; Tammela J; Intengan M; Beck A; Keitz B; Santiago D; Williamson B; Scanlan MJ; Ritter G; Chen YT; Driscoll D; Sood A; Lele S; Old LJ
Cancer Res; 2003 Sep; 63(18):6076-83. PubMed ID: 14522938
[TBL] [Abstract][Full Text] [Related]
4. Comparisons for detecting NY-ESO-1 mRNA expression levels in hepatocellular carcinoma tissues.
Wang XY; Chen HS; Luo S; Zhang HH; Fei R; Cai J
Oncol Rep; 2009 Mar; 21(3):713-9. PubMed ID: 19212631
[TBL] [Abstract][Full Text] [Related]
5. Frequency of NY-ESO-1 and LAGE-1 expression in bladder cancer and evidence of a new NY-ESO-1 T-cell epitope in a patient with bladder cancer.
Sharma P; Gnjatic S; Jungbluth AA; Williamson B; Herr H; Stockert E; Dalbagni G; Donat SM; Reuter VE; Santiago D; Chen YT; Bajorin DF; Old LJ
Cancer Immun; 2003 Dec; 3():19. PubMed ID: 14680360
[TBL] [Abstract][Full Text] [Related]
6. Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with derepression of this cancer-testis gene in lung cancer cells.
Hong JA; Kang Y; Abdullaev Z; Flanagan PT; Pack SD; Fischette MR; Adnani MT; Loukinov DI; Vatolin S; Risinger JI; Custer M; Chen GA; Zhao M; Nguyen DM; Barrett JC; Lobanenkov VV; Schrump DS
Cancer Res; 2005 Sep; 65(17):7763-74. PubMed ID: 16140944
[TBL] [Abstract][Full Text] [Related]
7. Expression of multiple cancer-testis antigen genes in gastrointestinal and breast carcinomas.
Mashino K; Sadanaga N; Tanaka F; Yamaguchi H; Nagashima H; Inoue H; Sugimachi K; Mori M
Br J Cancer; 2001 Sep; 85(5):713-20. PubMed ID: 11531257
[TBL] [Abstract][Full Text] [Related]
8. [Expression of NY-ESO-1/LAGE-1 genes in hepatocellular carcinoma and autologous humoral responses induced thereby].
Xing BC; Yuan YH; Hu ZG; Liu YX; Han Y; Liu N; Chen WF; Wang Y
Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(23):1980-2. PubMed ID: 15730810
[TBL] [Abstract][Full Text] [Related]
9. Expression profile of cancer-testis genes in 121 human colorectal cancer tissue and adjacent normal tissue.
Li M; Yuan YH; Han Y; Liu YX; Yan L; Wang Y; Gu J
Clin Cancer Res; 2005 Mar; 11(5):1809-14. PubMed ID: 15756003
[TBL] [Abstract][Full Text] [Related]
10. The alternative open reading frame of LAGE-1 gives rise to multiple promiscuous HLA-DR-restricted epitopes recognized by T-helper 1-type tumor-reactive CD4+ T cells.
Mandic M; Almunia C; Vicel S; Gillet D; Janjic B; Coval K; Maillere B; Kirkwood JM; Zarour HM
Cancer Res; 2003 Oct; 63(19):6506-15. PubMed ID: 14559844
[TBL] [Abstract][Full Text] [Related]
11. NY-ESO-1 and CTp11 expression may correlate with stage of progression in melanoma.
Goydos JS; Patel M; Shih W
J Surg Res; 2001 Jun; 98(2):76-80. PubMed ID: 11397121
[TBL] [Abstract][Full Text] [Related]
12. NY-ESO-1 expression and immunogenicity in esophageal cancer.
Fujita S; Wada H; Jungbluth AA; Sato S; Nakata T; Noguchi Y; Doki Y; Yasui M; Sugita Y; Yasuda T; Yano M; Ono T; Chen YT; Higashiyama M; Gnjatic S; Old LJ; Nakayama E; Monden M
Clin Cancer Res; 2004 Oct; 10(19):6551-8. PubMed ID: 15475443
[TBL] [Abstract][Full Text] [Related]
13. NY-ESO-1/LAGE-1 coexpression with MAGE-A cancer/testis antigens: a tissue microarray study.
Bolli M; Schultz-Thater E; Zajac P; Guller U; Feder C; Sanguedolce F; Carafa V; Terracciano L; Hudolin T; Spagnoli GC; Tornillo L
Int J Cancer; 2005 Jul; 115(6):960-6. PubMed ID: 15751033
[TBL] [Abstract][Full Text] [Related]
14. Expression and significance of cancer testis antigens in primary mucosal melanoma of the head and neck.
Prasad ML; Jungbluth AA; Patel SG; Iversen K; Hoshaw-Woodard S; Busam KJ
Head Neck; 2004 Dec; 26(12):1053-7. PubMed ID: 15515159
[TBL] [Abstract][Full Text] [Related]
15. Expression of MHC class I, MHC class II, and cancer germline antigens in neuroblastoma.
Wölfl M; Jungbluth AA; Garrido F; Cabrera T; Meyen-Southard S; Spitz R; Ernestus K; Berthold F
Cancer Immunol Immunother; 2005 Apr; 54(4):400-6. PubMed ID: 15449039
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of tumor antigens MAGE-A1, MAGE-A3/4, and NY-ESO-1 in cancerous and benign prostatic tissue.
Hudolin T; Juretic A; Spagnoli GC; Pasini J; Bandic D; Heberer M; Kosicek M; Cacic M
Prostate; 2006 Jan; 66(1):13-8. PubMed ID: 16114059
[TBL] [Abstract][Full Text] [Related]
17. Expression of MAGE-A1, MAGE-A3/4 and NY-ESO-1 cancer-testis antigens in fetal testis.
Hudolin T; Kastelan Z; Derezić D; Basić-Jukić N; Cesare Spagnoli G; Juretić A; Jezek D
Acta Dermatovenerol Croat; 2009; 17(2):103-7. PubMed ID: 19595265
[TBL] [Abstract][Full Text] [Related]
18. [Expression of NY-ESO-1 and LAGE-1 cancer-testis antigens in hepatocellular carcinoma].
Zhang WM; Xiao G; Zhang M; Guo AL; Dong Y; Wen JM
Zhonghua Bing Li Xue Za Zhi; 2005 Apr; 34(4):202-5. PubMed ID: 16091172
[TBL] [Abstract][Full Text] [Related]
19. Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma.
Sugita M; Geraci M; Gao B; Powell RL; Hirsch FR; Johnson G; Lapadat R; Gabrielson E; Bremnes R; Bunn PA; Franklin WA
Cancer Res; 2002 Jul; 62(14):3971-9. PubMed ID: 12124329
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and therapeutic relevance of NY-ESO-1 expression in oral squamous cell carcinoma.
Ries J; Mollaoglu N; Vairaktaris E; Neukam FW; Nkenke E
Anticancer Res; 2009 Dec; 29(12):5125-30. PubMed ID: 20044626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]